Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
CLK1/4-IN-2
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | CLK1/4-IN-2 is a selective inhibitor of CLK1/4 with an IC50 of 7 nM for CLK1 and 2.3 nM for CLK4. It induces protein depletion in cancer cells and exhibits anticancer activity. CLK1/4-IN-2 is applicable in research related to breast cancer, monocytic leukemia, bladder cancer, mammary adenocarcinoma, and hepatocellular carcinoma. |
| Targets & IC50 | CLK1:7 nM |
| In vitro | CLK1/4-IN-2 effectively inhibits the proliferation of human cancer cell lines within 2-5 days while demonstrating low cytotoxicity toward non-tumorigenic peripheral blood lymphocytes and HEK293 cells. In concentrations ranging from 1.25-20 μM over 3 days, it reduces levels of cancer-related proteins [EGFR and HDAC1 in T24 cells; EGFR and p70S6 kinase in MDA-MB-231 cells; HDAC1 and p70S6 kinase in HepG2 cells], correlating with the sensitivity of cell lines to proliferation inhibition. |
| Molecular Weight | 329.39 |
| Formula | C18H16FNO2S |
| Cas No. | 2101206-26-0 |
| Smiles | O=C(C=1SC=2C=CC(OC)=CC2C1)N(C)CC=3C=CC=C(F)C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.